ES2031510T3 - N-fenil-butenamidas con propiedades farmaceuticas. - Google Patents
N-fenil-butenamidas con propiedades farmaceuticas.Info
- Publication number
- ES2031510T3 ES2031510T3 ES198787306988T ES87306988T ES2031510T3 ES 2031510 T3 ES2031510 T3 ES 2031510T3 ES 198787306988 T ES198787306988 T ES 198787306988T ES 87306988 T ES87306988 T ES 87306988T ES 2031510 T3 ES2031510 T3 ES 2031510T3
- Authority
- ES
- Spain
- Prior art keywords
- replaced
- alkyl
- hydrogen
- optionally
- halo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
- 150000001721 carbon Chemical class 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 150000001602 bicycloalkyls Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical class [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
- C07D261/16—Benzene-sulfonamido isoxazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
COMPUESTOS DE LA FORMULA (I) TIENEN PROPIEDADES FARMACEUTICAS EN LA CUAL X ES R1(HO)C=C(CN)-,R''(CO)-CH(CN)- O R1 Y R2 SON CADA UNO HIDROGENO, O C1-6 ALQUIL, R3, R4 Y R5 SON CADA UNO HIDROGENO, HIDROXI, HALOGENO, NITRO, CIANO, CARBOXI, C1-4 ALQUILO, C1-4 ALCOXI, C1-4 TIOALQUILO, C1-4 ALCOXI HALO SUSTITUIDO, C1-4 TIOALQUILO HALO SUSTITUIDO, C2-5 ALCOXI CARBONILO, OPCIONALMENTE FENIL SUSTITUIDO, OPCIONALMENTE FENOXI SUSTITUIDO, R'', R"N- DONDE R'' Y R" SON CADA UNO HIDROGENO O C1-4 ALQUILO O R"''CONH- DONDE R"'' ES C1-4 ALQUILO, R6, R7 Y R8 SON CADA UNO C1-6 ALQUILO, C1-6 ALQUILO HALO SUSTITUIDO O FENIL SUSTITUIDO OPCIONALMENTE, O R6 Y R7 JUNTOS CON EL ATOMO DE CARBONO, AL CUAL ESTAN UNIDOS FORMAN UN GRUPO CICLOALQUILO QUE CONTIENE DE 3 A 7 ATOMOS DE CARBONO, O R6 R7 Y R8 JUNTOS CON EL ATOMO DE CARBONO AL QUE ESTAN UNIDOS, FORMAN UN GRUPO BICICLOALQUILO QUE CONTIENE DE 4 A 9 ATOMOS DE CARBONO, Y SUS SALES.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868619432A GB8619432D0 (en) | 1986-08-08 | 1986-08-08 | Pharmaceutical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2031510T3 true ES2031510T3 (es) | 1992-12-16 |
Family
ID=10602473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES198787306988T Expired - Lifetime ES2031510T3 (es) | 1986-08-08 | 1987-08-06 | N-fenil-butenamidas con propiedades farmaceuticas. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4892963A (es) |
| EP (1) | EP0257882B1 (es) |
| JP (1) | JPS63239259A (es) |
| KR (2) | KR880002823A (es) |
| CN (1) | CN1015256B (es) |
| AR (2) | AR244660A1 (es) |
| AT (1) | ATE65494T1 (es) |
| AU (1) | AU604737B2 (es) |
| CA (1) | CA1317964C (es) |
| DE (1) | DE3771611D1 (es) |
| DK (1) | DK169404B1 (es) |
| EG (1) | EG18269A (es) |
| ES (1) | ES2031510T3 (es) |
| GB (1) | GB8619432D0 (es) |
| GR (1) | GR3002714T3 (es) |
| HU (1) | HU197559B (es) |
| IL (1) | IL83432A (es) |
| MX (1) | MX174371B (es) |
| NZ (1) | NZ221352A (es) |
| PH (1) | PH22821A (es) |
| PT (1) | PT85476B (es) |
| RU (1) | RU1771472C (es) |
| ZA (1) | ZA875813B (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5268382A (en) * | 1985-09-27 | 1993-12-07 | Hoechst Aktiengesellschaft | Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus |
| DE3534440A1 (de) * | 1985-09-27 | 1987-04-02 | Hoechst Ag | Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes |
| US4975462A (en) * | 1988-07-29 | 1990-12-04 | Bristol-Myers Company | Antiarthritic α-arylcarbamoyl cyanoacetic acid derivatives |
| US5583150A (en) * | 1989-08-18 | 1996-12-10 | Alcon Laboratories, Inc. | 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases |
| DD297328A5 (de) * | 1989-08-18 | 1992-01-09 | �������@���������k���Kk�� | 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen |
| US5108999A (en) * | 1990-02-02 | 1992-04-28 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
| US5001124A (en) * | 1990-02-02 | 1991-03-19 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
| JPH04211048A (ja) * | 1990-03-05 | 1992-08-03 | Mitsubishi Kasei Corp | チオカルバモイルアセトニトリル誘導体 |
| HU222234B1 (hu) * | 1990-05-18 | 2003-05-28 | Aventis Pharma Deutschland Gmbh. | Eljárás izoxazol-4-karbonsav-amidok és hidroxi-alkilidén-cián-ecetsav-amidok, a vegyületeket tartalmazó gyógyászati készítmények és az ismert vegyületeket tartalmazó rákellenes hatású gyógyszerkészítmények előállítására |
| IL102790A (en) * | 1991-09-17 | 1996-01-31 | Roussel Uclaf | 3-Cycloalkyl-prop-2- enamide derivatives |
| ATE128353T1 (de) * | 1991-10-23 | 1995-10-15 | Hoechst Ag | N-phenyl-2-cyano-3-hydroxycrotonsäureamidderiva e und deren verwendung als arzneimittel mit immunmodulatorischer eigenschaft. |
| GB9200275D0 (en) * | 1992-01-08 | 1992-02-26 | Roussel Lab Ltd | Chemical compounds |
| TW314467B (es) * | 1993-03-31 | 1997-09-01 | Hoechst Ag | |
| WO1994024095A1 (en) * | 1993-04-16 | 1994-10-27 | Abbott Laboratories | Immunosuppressive agents |
| GB9320299D0 (en) * | 1993-10-01 | 1993-11-17 | Roussel Lab Ltd | Isoxazole derivatives |
| ES2148561T3 (es) * | 1994-10-17 | 2000-10-16 | Aventis Pharma Ltd | Prevencion y curacion de enfermedades alergicas de tipo i. |
| DE19702988A1 (de) | 1997-01-28 | 1998-07-30 | Hoechst Ag | Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika |
| HRP20050176A2 (en) * | 1999-12-16 | 2005-08-31 | Teva Pharmaceutical Industries Ltd. | Novel processes for making - and a new crystalline form of-leflunomide |
| YU61602A (sh) * | 2000-02-15 | 2006-01-16 | Teva Pharmaceutical Industries Ltd. | Postupak za dobijanje leflunomida |
| DE10311763A1 (de) * | 2003-03-18 | 2004-10-07 | Aventis Pharma Deutschland Gmbh | Verfahren zur Herstellung von 2-Cyan-3-hydroxy-N-(phenyl)but-2-enamiden |
| US6894184B2 (en) | 2003-03-18 | 2005-05-17 | Aventis Pharma Deutschland Gmbh | Process for preparing 2-cyano-3-hydroxy-N-(phenyl)but-2-enamides |
| US20160287549A1 (en) | 2013-11-22 | 2016-10-06 | Genzyme Corporation | Novel methods for treating neurodegenerative diseases |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL186239B (nl) * | 1975-06-05 | Hoechst Ag | Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze. | |
| DK545976A (da) * | 1975-12-11 | 1977-06-12 | Hoechst Ag | Cyaneddikesyreanilidderivater fremgangsmade til deres fremstilling og midler der indeholder disse forbindelser |
| DE2654797A1 (de) * | 1976-12-03 | 1978-06-08 | Hoechst Ag | Verfahren zur herstellung von isoxazolderivaten |
| DE2655009A1 (de) * | 1976-12-04 | 1978-06-15 | Hoechst Ag | Isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel |
| EP0143142A3 (de) * | 1979-06-11 | 1985-07-17 | Ciba-Geigy Ag | Alphacarbamoyl-pyrrolpropionitrile, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung |
-
1986
- 1986-08-08 GB GB868619432A patent/GB8619432D0/en active Pending
-
1987
- 1987-08-02 EG EG448/87A patent/EG18269A/xx active
- 1987-08-03 PH PH35615A patent/PH22821A/en unknown
- 1987-08-04 IL IL83432A patent/IL83432A/xx not_active IP Right Cessation
- 1987-08-04 PT PT85476A patent/PT85476B/pt not_active IP Right Cessation
- 1987-08-05 NZ NZ221352A patent/NZ221352A/xx unknown
- 1987-08-05 CA CA000543739A patent/CA1317964C/en not_active Expired - Fee Related
- 1987-08-06 EP EP87306988A patent/EP0257882B1/en not_active Expired - Lifetime
- 1987-08-06 DE DE8787306988T patent/DE3771611D1/de not_active Expired - Fee Related
- 1987-08-06 ES ES198787306988T patent/ES2031510T3/es not_active Expired - Lifetime
- 1987-08-06 AT AT87306988T patent/ATE65494T1/de active
- 1987-08-06 RU SU874203189A patent/RU1771472C/ru active
- 1987-08-06 MX MX007668A patent/MX174371B/es unknown
- 1987-08-06 ZA ZA875813A patent/ZA875813B/xx unknown
- 1987-08-07 CN CN87105516A patent/CN1015256B/zh not_active Expired
- 1987-08-07 US US07/083,538 patent/US4892963A/en not_active Expired - Fee Related
- 1987-08-07 JP JP62198006A patent/JPS63239259A/ja active Pending
- 1987-08-07 HU HU873604A patent/HU197559B/hu not_active IP Right Cessation
- 1987-08-07 AR AR87308368A patent/AR244660A1/es active
- 1987-08-07 DK DK413987A patent/DK169404B1/da not_active IP Right Cessation
- 1987-08-07 AU AU76681/87A patent/AU604737B2/en not_active Ceased
- 1987-08-07 KR KR1019870008651A patent/KR880002823A/ko not_active Ceased
- 1987-08-07 KR KR1019870008650A patent/KR880002815A/ko not_active Ceased
-
1991
- 1991-09-12 GR GR91401318T patent/GR3002714T3/el unknown
-
1992
- 1992-11-20 AR AR92323708A patent/AR247876A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| DK413987A (da) | 1988-02-09 |
| CA1317964C (en) | 1993-05-18 |
| RU1771472C (ru) | 1992-10-23 |
| PT85476A (en) | 1987-09-01 |
| CN1015256B (zh) | 1992-01-01 |
| HU197559B (en) | 1989-04-28 |
| GR3002714T3 (en) | 1993-01-25 |
| MX7668A (es) | 1993-08-01 |
| DE3771611D1 (de) | 1991-08-29 |
| DK169404B1 (da) | 1994-10-24 |
| KR880002815A (ko) | 1988-05-11 |
| EP0257882B1 (en) | 1991-07-24 |
| EP0257882A1 (en) | 1988-03-02 |
| HUT44523A (en) | 1988-03-28 |
| AR244660A1 (es) | 1993-11-30 |
| NZ221352A (en) | 1989-10-27 |
| KR880002823A (ko) | 1988-05-11 |
| JPS63239259A (ja) | 1988-10-05 |
| US4892963A (en) | 1990-01-09 |
| MX174371B (es) | 1994-05-11 |
| AR247876A1 (es) | 1995-04-28 |
| EG18269A (en) | 1992-12-30 |
| GB8619432D0 (en) | 1986-09-17 |
| DK413987D0 (da) | 1987-08-07 |
| IL83432A (en) | 1992-06-21 |
| AU7668187A (en) | 1988-02-11 |
| IL83432A0 (en) | 1988-01-31 |
| ZA875813B (en) | 1989-04-26 |
| PT85476B (pt) | 1990-06-29 |
| ATE65494T1 (de) | 1991-08-15 |
| CN87105516A (zh) | 1988-02-24 |
| PH22821A (en) | 1989-01-19 |
| AU604737B2 (en) | 1991-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2031510T3 (es) | N-fenil-butenamidas con propiedades farmaceuticas. | |
| ES2121836T3 (es) | Aminoguanidinas. | |
| ES2062974T3 (es) | Compuestos de cefalosporina, procedimientos para su preparacion y agentes antibacterianos. | |
| ES2059335T3 (es) | Derivados de pirido(3,2,1-ij)-1,3,4-benzoxadiazina, procedimiento para su obtencion, preparados farmaceuticos correspondientes y productos intermedios utilizables en el procedimiento. | |
| ES2040879T3 (es) | Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina. | |
| ES2061845T3 (es) | Un procedimiento para preparar un compuesto espiro. | |
| ES2063153T3 (es) | Amino-4 quinoleinas y naftiridinas, su procedimiento de preparacion y su aplicacion como medicamentos. | |
| ES2078324T3 (es) | Pteridina-4 (3h)-onas, procedimientos de preparacion y medicamentos que los contienen. | |
| PE49696A1 (es) | Compuesto carbociclico | |
| DE69310602D1 (de) | 3',5'-Ditertbutyl-4'-Hydroxyflavone, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzung mit Antioxidations- und Antivasokonstriktionsaktivität | |
| KR890006641A (ko) | 신규의 옥사씨올란 유도체 | |
| DE69031913D1 (de) | Antivirale mittel | |
| ES8802141A1 (es) | Un procedimiento para la sintesis de derivados de imidazol. | |
| ES2070238T3 (es) | Emulsion de lipidos que contiene un analogo de prostaglandina. | |
| AR246256A1 (es) | Procedimiento de preparacion de compuestos pirrolicos sustituidos. | |
| ES2059626T3 (es) | Nuevos esteres de estramustina. | |
| ES2143675T3 (es) | Bencenosulfonil-ureas-tioureas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene. | |
| ES2058064T3 (es) | Derivados de beta-carbolina sustituidos con fenoxi, su preparacion y su utilizacion como medicamentos. | |
| ES2028877T3 (es) | Un procedimiento para preparar un compuesto heterociclico. | |
| DK161200C (da) | 11-substituerede 5,11-dihydro-6h-pyridooe2,3-baaoe1,4aa-benzodiazepin-6-oner, fremgangsmaade til fremstilling heraf, laegemiddel indeholdende en saadan forbindelse samt anvendelse af en saadan forbindelse tilfremstilling af laegemidler | |
| AR248276A1 (es) | Derivados de imidazolidina, procedimiento para producirlos y pesticidas que los contienen | |
| AR246972A1 (es) | Un procedimiento para producir compuestos de benzodiazepina, y compuestos intermediarios utiles en dicho procedimiento. | |
| ATE140693T1 (de) | Phenylalkylaminoalkyl-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| ES8802489A1 (es) | Procedimiento para la obtencion de benzamidas | |
| ES2159693T3 (es) | Ligandos 5ht1dalfa y 5ht2a. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 257882 Country of ref document: ES |